# Entero Healthcare Solutions Limited (ENTERO)

> ENTERO closed at ₹1,565.00 on 30 Oct 2026, trailing P/E 54.3, market cap ₹6,811 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Entero Healthcare Solutions Limited (NSE: ENTERO) closed at ₹1,565.00 on 30 Oct 2026, +41.4% over one year, against a 52-week range of ₹944.00 – ₹1,920.00.

In the quarter ended 30 Jun 2026 (consolidated, filed 7 Aug 2026) it reported revenue of ₹1,940 cr and net profit of ₹38 cr, a 2.0% net margin; revenue grew 38.2% and profit grew 84.6% year on year.

On four consecutive filed quarters its trailing P/E is 54.3; since 27 May 2025 its own P/E has ranged from 38.6 to 67.0 (median 50.7), and today's reading is higher than 72% of those 353 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 9.0%, ROCE 17.4%, debt-to-equity 0.34, Piotroski F-score 5 of 9.

Against 40 Consumer Services peers on NSE: Net margin higher than 28% of 40 sector peers; PBT margin higher than 30% of 40 sector peers; ROE higher than 46% of 40 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹1,565.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -15.5% / +25.2% / +41.4% |
| 52-week low – high | ₹944.00 – ₹1,920.00 |
| Market capitalisation | ₹6,811 cr |
| Trailing P/E | 54.3 |
| Price / book | 4.03 |
| EV / EBITDA | 22.5 |
| Earnings yield | 1.8% |
| TTM EPS | ₹28.81 |
| TTM net profit | ₹125 cr |
| Quarter revenue | ₹1,940 cr |
| Quarter net profit | ₹38 cr |
| Net margin | 2.0% |
| Revenue growth (YoY) | +38.2% |
| Profit growth (YoY) | +84.6% |
| Return on equity | 9.0% |
| ROCE | 17.4% |
| Debt / equity | 0.34 |
| Current ratio | 1.58 |
| Free cash flow | ₹29 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹20.6 cr |

## Questions

### What is the P/E ratio of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited's trailing P/E is 54.3, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 27 May 2025 its P/E has ranged 38.6–67.0.

### What were Entero Healthcare Solutions Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Entero Healthcare Solutions Limited reported revenue of ₹1,940 cr and net profit of ₹38 cr (consolidated), filed with the exchange on 7 Aug 2026.

### What is Entero Healthcare Solutions Limited's ROE?

Return on equity is 9.0% based on the balance sheet dated 31 Mar 2026.

### Does Entero Healthcare Solutions Limited have debt?

Debt-to-equity is 0.34 on the balance sheet dated 31 Mar 2026.

### What is ENTERO's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, ENTERO traded between ₹944.00 and ₹1,920.00.

Sector: [Consumer Services](https://trinetra.trade/sectors/consumer-services) · Page: https://trinetra.trade/fundamentals/ENTERO

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._